Diagnostic options · UAE

Genetic tests in Dubai & UAE

Compare available Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

805

Listed price range

600.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic test prices

Showing 496–510 of 805 matching tests.

Genetic diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-2772 Next-Generation Sequencing (NGS) for Retinitis Pigmentosa (RP) Test This test identifies genetic mutations in over 80 genes associated with Retinitis Pigmentosa.	Peripheral whole blood	45 working days	3,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in RP-associated genes", "Genetic mutations linked to retinal degeneration"] Parameters [] Preparation ["No specific fasting required", "Avoid blood transfusion within the last 3 months", "Discontinue active chemotherapy or immunosuppressive therapy if possible"] Indications ["Suspected diagnosis of Retinitis Pigmentosa", "Family history of inherited retinal dystrophy", "Need for genetic counselling regarding RP"] Measurement technique Confirm with laboratory Codes LOINC: 95938-3 ICD-10: H35.52 Clinical summary This test identifies genetic mutations in over 80 genes associated with Retinitis Pigmentosa.
TEST-2733 Next-Generation Sequencing (NGS) Hereditary Retinoblastoma Test This test identifies germline mutations within the RB1 gene associated with hereditary retinoblastoma.	Whole Blood	45 working days	3,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["RB1 gene mutations", "Germline genetic predisposition"] Parameters [] Preparation [] Indications ["Suspected hereditary retinoblastoma", "Family history of retinoblastoma", "Genetic counselling for at-risk families"] Measurement technique Confirm with laboratory Codes LOINC: 21644-2 ICD-10: C69.2, Z15.01 Clinical summary This test identifies germline mutations within the RB1 gene associated with hereditary retinoblastoma.
TEST-2721 Next-Generation Sequencing: Alexander Disease Test This test identifies mutations in the GFAP gene associated with Alexander disease, a rare neurodegenerative disorder.	Peripheral Whole Blood	40 working days (approximately 8 weeks)	2,600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["GFAP gene mutations", "Genetic variants associated with Alexander Disease"] Parameters [{"name": "Diagnostic Sensitivity", "reference_range": "99.9%"}] Preparation ["No specific fasting required", "No medication adjustments needed unless advised by physician"] Indications ["Symptomatic patients suspected of Alexander disease", "Carrier status determination in siblings of confirmed cases", "Patients with macrocephaly, developmental regression, spasticity, and seizure disorders"] Measurement technique Confirm with laboratory Codes LOINC: 82313-0 ICD-10: G93.8 Clinical summary This test identifies mutations in the GFAP gene associated with Alexander disease, a rare neurodegenerative disorder.
TEST-2724 Next‑Generation Sequencing (NGS) Alzheimer’s Disease Genetic Test This diagnostic test evaluates for pathogenic variants in genes associated with Alzheimer's disease risk (APP, PSEN1, PSEN2) and the APOE genotype.	Peripheral Whole Blood	40 Working Days	2,600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in APP gene", "Pathogenic variants in PSEN1 gene", "Pathogenic variants in PSEN2 gene", "APOE genotype (ε2/ε3/ε4 alleles)"] Parameters [] Preparation ["No specific fasting required", "Inform the phlebotomist about any medications being taken"] Indications ["Individuals with a family history of early-onset Alzheimer's disease", "Patients experiencing cognitive symptoms suggestive of Alzheimer's disease", "Proactive risk assessment for individuals concerned about Alzheimer's susceptibility"] Measurement technique Confirm with laboratory Codes LOINC: 101260-9 ICD-10: G30.9, Z13.858 Clinical summary This diagnostic test evaluates for pathogenic variants in genes associated with Alzheimer's disease risk (APP, PSEN1, PSEN2) and the APOE genotype.
TEST-2722 Next‑Generation Sequencing (NGS) for Dementia Genetic Testing Test This test identifies pathogenic variants in genes linked to Alzheimer's disease, frontotemporal dementia, Lewy body dementia, and other neurodegenerative disorders using Next-Gener...	Whole blood (10 mL, 5 mL min.) in 2 Lavender Top EDTA tubes	40 working days	2,600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in dementia-associated genes", "Copy Number Variants (CNVs)"] Parameters [] Preparation [] Indications ["Diagnosis of early-onset dementia", "Differential diagnosis of dementia subtypes", "Genetic counselling for families with dementia history"] Measurement technique Confirm with laboratory Codes LOINC: 89359-8 ICD-10: G30.9, G31.09, G31.83 Clinical summary This test identifies pathogenic variants in genes linked to Alzheimer's disease, frontotemporal dementia, Lewy body dementia, and other neurodegenerative disorders using Next-Generation Sequencing.
TEST-2716 Next‑Generation Sequencing (NGS) for Hereditary Cataract Test This test identifies pathogenic DNA variants across all known genes associated with inherited lens opacities (cataracts).	Peripheral Whole Blood (EDTA)	45 Working Days	3,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic DNA variants in cataract-associated genes"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any bleeding disorders"] Indications ["Diagnosis of hereditary cataract", "Genetic counseling for families with hereditary cataract", "Pre-implantation genetic diagnosis (PGD) planning"] Measurement technique Confirm with laboratory Codes LOINC: 81409-5 ICD-10: Q12.0 Clinical summary This test identifies pathogenic DNA variants across all known genes associated with inherited lens opacities (cataracts).
TEST-2753 Next‑Generation Sequencing (NGS) Glaucoma Genetic Panel Test This test evaluates genetic variants in over 20 genes associated with glaucoma risk.	Whole Blood (Peripheral Venipuncture)	45 working days	3,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in glaucoma-associated genes", "Copy Number Variants (CNVs) in glaucoma-associated genes"] Parameters [] Preparation ["No fasting required", "Maintain normal hydration and diet", "Wear a short-sleeved shirt"] Indications ["Definitive risk assessment", "Familial screening", "Diagnostic confirmation", "Presymptomatic testing"] Measurement technique Confirm with laboratory Codes LOINC: 92855-7 ICD-10: H40.0, H40.1, Z15.89 Clinical summary This test evaluates genetic variants in over 20 genes associated with glaucoma risk.
TEST-2338 NHEJ1 Gene Sequencing for Severe Combined Immunodeficiency with Microcephaly, Growth Retardation & Radiosensitivity Test This diagnostic test evaluates the NHEJ1 gene for pathogenic variants associated with severe combined immunodeficiency (SCID) and related clinical features.	Peripheral Whole Blood	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the NHEJ1 gene", "Detection of novel and deep intronic variants"] Parameters [] Preparation ["Maintain regular hydration", "Avoid fatty meals two hours before collection", "Continue all prescribed medications unless advised otherwise"] Indications ["Diagnosis of SCID with associated features", "Identification of NHEJ1 gene mutations"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: D81.8 Clinical summary This diagnostic test evaluates the NHEJ1 gene for pathogenic variants associated with severe combined immunodeficiency (SCID) and related clinical features.
TEST-5240 NHP2 Gene Dyskeratosis Congenita, Autosomal Recessive Type 2 Genetic Test This genetic test sequences the NHP2 gene to detect pathogenic variants associated with autosomal recessive dyskeratosis congenita type 2.	Whole Blood, Extracted DNA, or One-Drop Blood on FTA Card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the NHP2 gene"] Parameters [] Preparation ["Attend a pre-test genetic counselling session", "Document a three-generation pedigree chart"] Indications ["Clinical suspicion of dyskeratosis congenita", "Family history of dyskeratosis congenita", "Evaluation of bone marrow failure or malignancy risk"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: D61.0 Clinical summary This genetic test sequences the NHP2 gene to detect pathogenic variants associated with autosomal recessive dyskeratosis congenita type 2.
TEST-3991 NKX2-1 Gene Hereditary Benign Chorea Genetic Test This test evaluates the NKX2-1 gene for pathogenic mutations associated with hereditary benign chorea.	Whole Blood (Peripheral) or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic mutations in the NKX2-1 gene", "Exonic regions ±20bp intronic borders of the NKX2-1 gene"] Parameters [] Preparation ["No specific physical preparation needed", "Have family medical history information available for genetic counselling"] Indications ["Suspected hereditary benign chorea", "Differential diagnosis of chorea", "Familial risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 49266-4 ICD-10: G25.5 Clinical summary This test evaluates the NKX2-1 gene for pathogenic mutations associated with hereditary benign chorea.
TEST-4481 NLRP1 Gene Autoimmune Susceptibility Genetic Test This genetic test evaluates the NLRP1 gene for variants associated with autoimmune susceptibility, particularly vitiligo.	Peripheral blood, buccal swab, or FTA card	4 to 5 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["NLRP1 gene variants", "Genetic susceptibility to autoimmune conditions"] Parameters [] Preparation ["No special fasting is needed"] Indications ["Refining diagnosis of autoimmune disorders", "Assessing familial risk", "Guiding autoimmune surveillance protocols"] Measurement technique Confirm with laboratory Codes LOINC: 82939-0 ICD-10: L80, Z13.89 Clinical summary This genetic test evaluates the NLRP1 gene for variants associated with autoimmune susceptibility, particularly vitiligo.
TEST-3619 NLRP1 Gene Corneal Intraepithelial Dyskeratosis and Ectodermal Dysplasia NGS Test This diagnostic test evaluates the NLRP1 gene for pathogenic variants associated with corneal intraepithelial dyskeratosis and ectodermal dysplasia.	Peripheral Whole Blood (also accepts extracted DNA / FTA card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy number variations (CNVs)"] Parameters [] Preparation [] Indications ["Diagnosis of corneal intraepithelial dyskeratosis", "Diagnosis of ectodermal dysplasia", "Familial risk assessment for at-risk relatives"] Measurement technique Confirm with laboratory Codes LOINC: 94222-8 ICD-10: Q82.4, H18.89 Clinical summary This diagnostic test evaluates the NLRP1 gene for pathogenic variants associated with corneal intraepithelial dyskeratosis and ectodermal dysplasia.
TEST-5321 NLRP12 Gene Sequencing for Cold Autoinflammatory Syndrome Type 2 (CAPS2) Test This diagnostic test evaluates the NLRP12 gene for pathogenic variants associated with Cold Autoinflammatory Syndrome Type 2 (CAPS2).	Whole Blood (EDTA) or Buccal Swab	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["NLRP12 gene coding region", "Pathogenic variants (SNVs, indels, CNVs, deep intronic variants)"] Parameters [] Preparation ["No fasting required", "Standard hygiene protocols for phlebotomy apply"] Indications ["Suspected Cold Autoinflammatory Syndrome Type 2 (CAPS2)", "Hereditary periodic fever syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 98238-5 ICD-10: M04.2 Clinical summary This diagnostic test evaluates the NLRP12 gene for pathogenic variants associated with Cold Autoinflammatory Syndrome Type 2 (CAPS2).
TEST-6398 NNT Gene Glucocorticoid Deficiency Type 4 (With or Without Mineralocorticoid Deficiency) Test This test identifies genetic mutations in the NNT gene responsible for hereditary glucocorticoid deficiency type 4.	Whole Blood (EDTA), Extracted Genomic DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["NNT gene sequence", "Pathogenic variants (SNVs, indels, CNVs)"] Parameters [] Preparation ["No fasting or medication adjustments required", "Mandatory pre-test genetic counselling session"] Indications ["Suspected Glucocorticoid Deficiency Type 4", "Confirmation of diagnosis in patients with relevant clinical and biochemical findings"] Measurement technique Confirm with laboratory Codes LOINC: 81247-7 ICD-10: E27.1, E27.40, Z13.228 Clinical summary This test identifies genetic mutations in the NNT gene responsible for hereditary glucocorticoid deficiency type 4.
TEST-3769 NOS3 (eNOS) Gene Alzheimer's Disease Susceptibility Test (NGS) This test evaluates variants in the NOS3 gene associated with increased susceptibility to Alzheimer's disease.	Peripheral whole blood or FTA card (buccal swab acceptable after consultation)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["NOS3 gene variants", "Endothelial nitric oxide synthase (eNOS) function related to cerebral blood flow"] Parameters [] Preparation [] Indications ["Risk assessment for late-onset Alzheimer's disease", "Personalized risk reduction strategies", "Integration with clinical assessment for neurological conditions"] Measurement technique Confirm with laboratory Codes LOINC: 21632-5 ICD-10: Z13.82 Clinical summary This test evaluates variants in the NOS3 gene associated with increased susceptibility to Alzheimer's disease.

Category overview

Genetic: overview

Unlocking the blueprint of your DNA provides profound, proactive insights into your family’s future and personal health risks. Integrated within our advanced Biochemistry and molecular services, specialized Genetic testing evaluates inherited traits, metabolic predispositions, and carrier statuses. Utilizing cutting-edge diagnostic technology, comprehensive genetic screening offers the vital clarity needed to safely guide tailored medical strategies and family planning. As an undisputed leader in innovation among diagnostic labs in Dubai and the UAE, DNA Labs guarantees the highest standards of strict patient confidentiality, unparalleled diagnostic precision, and rapid reporting. Empower your health decisions with certainty—book your genetic testing in UAE, coordinate a secure sample collection, or connect with our specialized genetics team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.